+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Breast Cancer Screening Market by Technology (2D Mammography, 3D Tomosynthesis, Magnetic Resonance Imaging), Age Group (40 To 49, 50 To 69, 70 And Above), Delivery Mode, End User - Global Forecast 2025-2030- Product Image
Breast Cancer Screening Market by Technology (2D Mammography, 3D Tomosynthesis, Magnetic Resonance Imaging), Age Group (40 To 49, 50 To 69, 70 And Above), Delivery Mode, End User - Global Forecast 2025-2030- Product Image
Sale

Breast Cancer Screening Market by Technology (2D Mammography, 3D Tomosynthesis, Magnetic Resonance Imaging), Age Group (40 To 49, 50 To 69, 70 And Above), Delivery Mode, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011427
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The breast cancer screening market is rapidly changing as technology advancements and evolving care protocols reshape how early detection is delivered and managed globally.

Market Snapshot: Breast Cancer Screening Market Growth and Dynamics

The Breast Cancer Screening Market grew from USD 5.31 billion in 2024 to USD 5.69 billion in 2025. It is expected to continue growing at a CAGR of 6.86%, reaching USD 7.91 billion by 2030. Market expansion is driven by heightened adoption of innovative imaging modalities, optimized screening pathways, and increased focus on preventive strategies. Accelerated uptake of artificial intelligence, cloud-based diagnostics, and integrated electronic health records supports broader access and improved workflow for healthcare providers. This sector’s robustness is further powered by ongoing regulatory alignment, shifting patient demographics, and emerging value-based reimbursement models.

Scope & Segmentation

  • Technology: 2D Mammography (Analog, Digital), 3D Tomosynthesis, Magnetic Resonance Imaging (Contrast Enhanced, Non Contrast), Molecular Breast Imaging (Breast Specific Gamma Imaging, Scintimammography), Thermography, Ultrasound (Automated, Handheld)
  • Age Group: Under 40, 40 To 49, 50 To 69, 70 And Above
  • Delivery Mode: Cloud (Software As A Service, Web Based), On Premise
  • End User: Ambulatory Care Centers, Clinics (Primary Care Clinics, Specialty Clinics), Diagnostic Centers (Chain Centers, Independent Centers), Hospitals (Private Hospitals, Public Hospitals)
  • Regional Coverage: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage: Hologic, Inc.; GE HealthCare; Siemens Healthineers AG; Koninklijke Philips N.V.; Fujifilm Holdings Corporation; Canon Medical Systems Corporation; Konica Minolta, Inc.; Shimadzu Corporation; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Carestream Health, Inc.

Key Takeaways: Strategic Insights for Decision Makers

  • Technological innovation is accelerating the development of advanced modalities, including AI-driven platforms and image interpretation tools, to refine early detection and reporting accuracy.
  • Patient engagement and streamlined care coordination are improving as mobile health applications and cloud-based infrastructure enable remote monitoring and seamless data integration.
  • Shifts in policy and reimbursement models are supporting value-based care, encouraging providers to focus on preventive screening and long-term risk management.
  • Regional differences require tailored solutions, as market maturity and healthcare infrastructure vary significantly between developed and emerging economies.
  • Collaboration among manufacturers, service providers, and regulatory agencies is fostering clinical research, integrated screening approaches, and rapid technology adoption.

Tariff Impact on Cost Structures and Supply Chains

The introduction of new US tariff measures in 2025 has altered equipment sourcing, production costs, and supply chain strategies for imaging component vendors. Market players are responding by increasing local partnerships and investing in domestic manufacturing to minimize tariff-related expenses and maintain steady technology deployment. Providers are leveraging creative financing, such as equipment-as-a-service models and outcome-focused contracts, to manage budgets and ensure consistent access to state-of-the-art screening solutions despite evolving trade conditions.

Methodology & Data Sources

This report integrates primary interviews with radiologists, hospital administrators, and industry suppliers alongside secondary research from peer-reviewed journals, regulatory filings, and patent databases. Rigorous data synthesis combines quantitative and qualitative methods, and all findings undergo multiple rounds of validation and expert review.

Why This Report Matters

  • Gain actionable insights into market drivers and evolving care models, supporting more informed investment and procurement decisions in the breast cancer screening market.
  • Understand the implications of emerging technologies, regional disparities, and tariff impacts to shape competitive strategies and operational planning.
  • Leverage comprehensive segmentation analysis for alignment of product and service offerings with the latest clinical and regulatory requirements.

Conclusion

Senior leaders can use this report to anticipate key market trends, address operational challenges, and identify new growth opportunities in breast cancer screening. Implementing the outlined strategies will support more effective, patient-centered care and sustained organizational advancement.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Clinical integration of AI-powered mammography algorithms to improve diagnostic accuracy and reduce false positives
5.2. Adoption of contrast-enhanced mammography techniques for more precise tumor visualization in dense breast tissue
5.3. Expansion of liquid biopsy screening solutions for noninvasive detection of early-stage breast cancer biomarkers
5.4. Deployment of portable ultrasound systems in underserved regions to enhance access to real-time breast imaging
5.5. Development of home-based self-sampling kits for circulating tumor DNA analysis in breast cancer screening
5.6. Government initiatives to implement risk-based personalized screening schedules for high-risk populations
5.7. Integration of telemammography platforms to facilitate remote expert consultations in rural healthcare settings
5.8. Emergence of deep learning triage tools for prioritizing abnormal mammograms and reducing radiologist workload
5.9. Implementation of value-based reimbursement models incentivizing early detection and quality of breast cancer screening
5.10. Post-pandemic screening catch-up programs leveraging mobile mammography units to address screening backlogs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Breast Cancer Screening Market, by Technology
8.1. Introduction
8.2. 2D Mammography
8.2.1. Analog
8.2.2. Digital
8.3. 3D Tomosynthesis
8.4. Magnetic Resonance Imaging
8.4.1. Contrast Enhanced
8.4.2. Non Contrast
8.5. Molecular Breast Imaging
8.5.1. Breast Specific Gamma Imaging
8.5.2. Scintimammography
8.6. Thermography
8.7. Ultrasound
8.7.1. Automated
8.7.2. Handheld
9. Breast Cancer Screening Market, by Age Group
9.1. Introduction
9.2. 40 To 49
9.3. 50 To 69
9.4. 70 And Above
9.5. Under 40
10. Breast Cancer Screening Market, by Delivery Mode
10.1. Introduction
10.2. Cloud
10.2.1. Software As A Service
10.2.2. Web Based
10.3. On Premise
11. Breast Cancer Screening Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Clinics
11.3.1. Primary Care Clinics
11.3.2. Specialty Clinics
11.4. Diagnostic Centers
11.4.1. Chain Centers
11.4.2. Independent Centers
11.5. Hospitals
11.5.1. Private Hospitals
11.5.2. Public Hospitals
12. Americas Breast Cancer Screening Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Breast Cancer Screening Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Breast Cancer Screening Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Hologic, Inc.
15.3.2. GE HealthCare
15.3.3. Siemens Healthineers AG
15.3.4. Koninklijke Philips N.V.
15.3.5. Fujifilm Holdings Corporation
15.3.6. Canon Medical Systems Corporation
15.3.7. Konica Minolta, Inc.
15.3.8. Shimadzu Corporation
15.3.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
15.3.10. Carestream Health, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BREAST CANCER SCREENING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BREAST CANCER SCREENING MARKET: RESEARCHAI
FIGURE 24. BREAST CANCER SCREENING MARKET: RESEARCHSTATISTICS
FIGURE 25. BREAST CANCER SCREENING MARKET: RESEARCHCONTACTS
FIGURE 26. BREAST CANCER SCREENING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BREAST CANCER SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIGITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D TOMOSYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON CONTRAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON CONTRAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST SPECIFIC GAMMA IMAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST SPECIFIC GAMMA IMAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SCINTIMAMMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SCINTIMAMMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY THERMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY THERMOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HANDHELD, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 40 TO 49, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 40 TO 49, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 50 TO 69, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 50 TO 69, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 70 AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 70 AND ABOVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY UNDER 40, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY UNDER 40, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE AS A SERVICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE AS A SERVICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY WEB BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY WEB BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ON PREMISE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIMARY CARE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CHAIN CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CHAIN CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY INDEPENDENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 149. CANADA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. CANADA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. CANADA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 152. CANADA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 153. CANADA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 154. CANADA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 155. CANADA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 156. CANADA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 157. CANADA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 158. CANADA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 159. CANADA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 160. CANADA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 161. CANADA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 162. CANADA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 163. CANADA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 164. CANADA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 165. CANADA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 168. CANADA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 169. CANADA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 170. CANADA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 171. CANADA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 172. CANADA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 176. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 178. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 194. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 298. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 299. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2024 (USD MILLION)
TABLE 300. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2025-2030 (USD MILLION)
TABLE 301. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2018-2024 (USD MILLION)
TABLE 302. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING, 2025-2030 (USD MILLION)
TABLE 303. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2018-2024 (USD MILLION)
TABLE 304. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY ULTRASOUND, 2025-2030 (USD MILLION)
TABLE 305. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 308. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 309. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2018-2024 (USD MILLION)
TABLE 310. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY CLOUD, 2025-2030 (USD MILLION)
TABLE 311. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 314. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 315. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2018-2024 (USD MILLION)
TABLE 316. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC CENTERS, 2025-2030 (USD MILLION)
TABLE 317. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 318. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 319. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 320. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 321. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2018-2024 (USD MILLION)
TABLE 322. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY 2D MAMMOGRAPHY, 2025-2030 (USD MILLION)
TABLE 323. FRANC

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Breast Cancer Screening market report include:
  • Hologic, Inc.
  • GE HealthCare
  • Siemens Healthineers AG
  • Koninklijke Philips N.V.
  • Fujifilm Holdings Corporation
  • Canon Medical Systems Corporation
  • Konica Minolta, Inc.
  • Shimadzu Corporation
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Carestream Health, Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.91 Billion
Compound Annual Growth Rate6.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Breast Cancer Screening Device Market by Technology (Digital Mammography, Magnetic Resonance Imaging, Positron Emission Tomography), Application (Diagnostic, Screening), End User - Global Forecast 2025-2030 - Product Image

Breast Cancer Screening Device Market by Technology (Digital Mammography, Magnetic Resonance Imaging, Positron Emission Tomography), Application (Diagnostic, Screening), End User - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030 - Product Image

Next-Generation Breast Cancer Diagnostic & Screening Market by Offerings (Digital Pathology, Imaging Technologies, Implantable Sensors), Test Type (Genetic Tests, Pathological Tests, Protein Marker Tests), Stage, Application, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Breast Cancer Screening Test - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 115 Pages
  • Global
From
Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report by Product (Platform-based, Instrument-based), Type (Imaging, Biopsy, Genomic Tests, Blood Tests), Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 110 Pages
  • Global
From
Breast Cancer Screening Test Global Market Report 2025 - Product Image

Breast Cancer Screening Test Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Market

The Breast Cancer Screening market is a key component of Women's Health. It is a preventative measure that helps to detect breast cancer in its early stages, when it is most treatable. Screening typically involves mammography, which is an X-ray imaging test that can detect changes in the breast tissue. Other screening methods include clinical breast exams, breast ultrasounds, and MRI scans. The Breast Cancer Screening market is a growing industry, with many companies offering services to women. These companies provide a range of services, from mammography to MRI scans, to help women detect breast cancer early. Companies in the Breast Cancer Screening market include Breastlink, Breast Cancer Diagnostics, and Breast Health Solutions. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.